Global Epidemiology of Plasmodium vivax

Global Epidemiology of Plasmodium vivax

Mostrar outras versões (1)

Plasmodium vivax is the most widespread human malaria, putting 2.5 billion people at risk of infection. Its unique biological and epidemiological characteristics pose challenges to control strategies which have been principally targeted against Plasmodium falciparum. Unlike P. falciparum, P. vivax i...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Howes, R, Battle, K, Mendis, K, Smith, D, Cibulskis, R, Baird, J, Hay, S
Formato:	Journal article
Publicado em:	American Society of Tropical Medicine and Hygiene 2016

Registros relacionados

Global epidemiology of Plasmodium vivax
por: Howes, R, et al.
Publicado em: (2016)

The global public health significance of Plasmodium vivax.
por: Battle, K, et al.
Publicado em: (2012)

The epidemiology of Plasmodium vivax. Preface.
por: Hay, S, et al.
Publicado em: (2013)

Geographical variation in Plasmodium vivax relapse
por: Battle, K, et al.
Publicado em: (2014)

Geographical variation in Plasmodium vivax relapse.
por: Battle, K, et al.
Publicado em: (2014)

Growing evidence of Plasmodium vivax across malaria-endemic Africa
por: Twohig, K, et al.
Publicado em: (2019)

The global burden of Plasmodium vivax malaria is obscure and insidious
por: Battle, KE, et al.
Publicado em: (2021)

Plasmodium vivax transmission in Africa
por: Howes, R, et al.
Publicado em: (2015)

Defining the relationship between Plasmodium vivax parasite rate and clinical disease.
por: Battle, K, et al.
Publicado em: (2015)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
por: Baird, J, et al.
Publicado em: (2018)

Epidemiology of Plasmodium vivax in Indonesia
por: Baird, J, et al.
Publicado em: (2016)

Global economic costs due to Plasmodium Vivax malaria treatment and the cost-benefit of radical cure
por: Devine, A, et al.
Publicado em: (2018)

Plasmodium vivax in the era of the shrinking P. falciparum map
por: Price, RN, et al.
Publicado em: (2020)

The burden of Plasmodium vivax malaria
por: Battle, K
Publicado em: (2015)

Plasmodium vivax Transmission in Africa.
por: Rosalind E Howes, et al.
Publicado em: (2015-11-01)

The role of cytokines in Plasmodium vivax malaria
por: K. N. Mendis, et al.
Publicado em: (1992-01-01)

A long neglected world malaria map: Plasmodium vivax endemicity in 2010.
por: Gething, P, et al.
Publicado em: (2012)

Growing evidence of Plasmodium vivax across malaria-endemic Africa.
por: Katherine A Twohig, et al.
Publicado em: (2019-01-01)

Attacking Plasmodium vivax
por: Baird, J
Publicado em: (2016)

Diagnosis and treatment of Plasmodium vivax malaria.
por: Baird, K, et al.
Publicado em: (2012)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
por: J. Kevin Baird, et al.
Publicado em: (2018-01-01)

Neglect of Plasmodium vivax malaria.
por: Baird, J
Publicado em: (2007)

Chloroquine resistance in Plasmodium vivax.
por: Baird, J
Publicado em: (2004)

The international limits and population at risk of Plasmodium vivax transmission in 2009
por: Guerra, C, et al.
Publicado em: (2010)

THE HUMAN LIVER AS A RESERVOIR OF INFECTION: THE EPIDEMIOLOGY AND CONTROL OF MALARIA CAUSED BY PLASMODIUM VIVAX
por: Baird, J
Publicado em: (2013)

Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax.
por: Gething, P, et al.
Publicado em: (2011)

Plasmodium falciparum and Plasmodium vivax epidemiology in an era of malaria elimination
por: E. Collins, et al.
Publicado em: (2020-12-01)

Resistance to therapies for infection by Plasmodium vivax.
por: Baird, J
Publicado em: (2009)

Pernicious and threatening Plasmodium vivax as reality.
por: Baird, J
Publicado em: (2014)

Plasmodium vivax malaria endemicity in Indonesia in 2010
por: Elyazar, I, et al.
Publicado em: (2012)

G6PD deficiency: global distribution, genetic variants and primaquine therapy.
por: Howes, R, et al.
Publicado em: (2013)

G6PD Deficiency. Global Distribution, Genetic Variants and Primaquine Therapy
por: Howes, R, et al.
Publicado em: (2013)

The effects of urbanization on global <it>Plasmodium vivax</it> malaria transmission
por: Qi Qiuyin, et al.
Publicado em: (2012-12-01)

CAN THE SPATIAL DISTRIBUTION OF DUFFY NEGATIVITY EXPLAIN PLASMODIUM VIVAX ABSENCE IN AFRICA?
por: Howes, R, et al.
Publicado em: (2009)

Diagnosis and treatment of Plasmodium vivax malaria
por: Baird, J, et al.
Publicado em: (2016)

Spatial Epidemiology of Plasmodium vivax, Afghanistan
por: Simon Brooker, et al.
Publicado em: (2006-10-01)

Epidemiology, drug resistance, and pathophysiology of Plasmodium vivax malaria
por: Kiran K Dayananda, et al.
Publicado em: (2018-01-01)

Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission
por: Michael T White, et al.
Publicado em: (2014-11-01)

Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study
por: Battle, K, et al.
Publicado em: (2019)

Management of Plasmodium vivax risk and illness in travelers
por: Baird, J
Publicado em: (2017)